Genmab — December 2021
-
Asian Shares Mostly Higher Ahead Of Christmas Break https://www.proinvestor.com/investornyt/754227/asian-shares-mostly-higher-ahead-of-christmas-break
-
Årets bedste julevideo. https://www.proinvestor.com/index.php?p=debat_1&postid=99675
-
God morgen.
-
Asien: Porteføljejusteringer giver vigende børsindeks https://www.proinvestor.com/investornyt/756154/asien-portefoljejusteringer-giver-vigende-borsindeks
-
Onsdagens aviser med Topdanmark, Novo Nordisk og Vestas
https://www.proinvestor.com/investornyt/756153/onsdagens-aviser-med-topdanmark-novo-nordisk-og-vestas -
Valuta: Investorerne står klippefast på sidelinjen https://www.proinvestor.com/investornyt/756155/valuta-investorerne-star-klippefast-pa-sidelinjen
-
WHO: Omikron udgør stadig en stor risiko https://www.proinvestor.com/investornyt/756159/who-omikron-udgor-stadig-en-stor-risiko
-
Aktier/tendens: Vestas og Mærsk i fokus i nytårsstille marked https://www.proinvestor.com/investornyt/756184/aktier-tendens-vestas-og-maersk-i-fokus-i-nytarsstille-marked
-
Aktier/middag: Vestas falder i stille marked trods flere ordrer https://www.proinvestor.com/investornyt/756233/aktier-middag-vestas-falder-i-stille-marked-trods-flere-ordrer
-
Kort video: Helge Larsen samler op på året der gik - et volatilt år kendetegnet ved corona og stigende inflation og dermed udsigten til stigende renter. Han ser på rotationen fra grønne vækst- og innovationsaktier til value. Desuden kommer han ind på, hvordan det er gået med sin egen portefølje. Og ikke mindst taler han om IPO's både globalt og på danske First North.https://www.proinvestor.com/index.php?p=debat_1&postid=99774
-
Janssen Submits Biologics License Application to U.S. FDA Seeking Approval of Teclistamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma https://www.prnewswire.com/news-releases/janssen-submits-biologics-license-application-to-us-fda-seeking-approval-of-teclistamab-for-the-treatment-of-patients-with-relapsed-or-refractory-multiple-myeloma-301451472.html
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind